Skip to main content
The HRT IndexFind My HRT Path
Guide to online menopause treatment for women who cannot take estrogen — non-hormone hot-flash and vaginal symptom options

Best Online Menopause Treatment If You Can’t Take Estrogen

HI
The HRT Index Editorial TeamIndependent women's health research
Published: Last reviewed:
Editorial research — not medically reviewed by a clinician. Why this label

Last verified: · By The HRT Index Editorial Team · Educational research — not individualized medical advice, and not reviewed by a clinician (our medical review policy).

Affiliate disclosure: some providers we mention pay us if you start care with them. That never buys a spot or a ranking — see how we handle affiliates.

Short answer:

You can still treat menopause without estrogen. For hot flashes and night sweats, there are three FDA-approved non-estrogen prescriptions — fezolinetant (Veozah), the newer elinzanetant (Lynkuet), and low-dose paroxetine (Brisdelle) — plus certain antidepressants and gabapentin used off-label, and behavioral therapies with real evidence. Vaginal symptoms have their own separate non-estrogen options. For most women who want to start online, Midi Health is our first pick for complex or cancer histories; Sesame is a clean cash-pay alternative. Both are below.

If a doctor told you to stop or avoid estrogen — or your own history made that call for you — you didn’t run out of options. You lost oneoption. That’s a real loss, and if you’re here because someone said “you’ll just have to ride it out,” we’re sorry. That advice is outdated.

So let’s answer the actual question: the best online menopause treatment if you can’t take estrogen isn’t a single pill. It’s a match between the symptom that’s wrecking your days and a provider who can prescribe the right non-estrogen treatment andmanage your history safely. This guide walks you through both — including one detail about tamoxifen that most pages get flat wrong, and why “non-hormonal” is not the same as “risk-free.”

We’re The HRT Index — the independent decision resource for online menopause and HRT care.We compare telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult. We don’t sell treatment. We help you pick the right door.

This page is for you if:

  • You’ve been told estrogen isn’t safe for you — a hormone-sensitive breast cancer, a blood clot, a stroke, liver disease — or you’ve decided you don’t want it.
  • You want real, evidence-based options, not a pitch or a supplement bundle.
  • You want to know which online provider actually prescribes these treatments, what it costs, and what to check before you pay.

This page is not for you if:

  • You can take estrogen and want the best hormone provider — start with our best online HRT providers guide.
  • You have new or unexplained vaginal bleeding that hasn’t been checked out yet. That needs an in-person evaluation first.
  • You need urgent care. This is a research guide, not an emergency service.

The right online provider isn’t the same for every woman. It depends on your symptoms, your age, your risk history, your insurance, and your state. Use The HRT Index’s Find My HRT Path tool to match your situation to the right provider in about 90 seconds.

Start Find My HRT Path →

Free, about 90 seconds.


Can you treat menopause without estrogen?

Yes. Estrogen is the single most effective treatment for menopause symptoms — but it is not the only one, and “no estrogen” does not mean “no treatment.” There are FDA-approved non-estrogen medicines for hot flashes, a separate set of non-estrogen options for vaginal and bladder symptoms, and behavioral therapies with real evidence behind them. The best fit depends on why you can’t take estrogen and which symptoms bother you most.

Here’s the reframe that changes everything. “Menopause” isn’t one problem, so it doesn’t have one fix. Most treatment decisions split into two very different buckets:

Bucket 1: Hot flashes & night sweats

Doctors call these vasomotor symptoms (VMS). They come from your brain’s temperature control, and you treat them with something that works body-wide (systemic).

Bucket 2: Vaginal dryness, painful sex, urinary symptoms

Doctors call this genitourinary syndrome of menopause (GSM). These come from thinning tissue in one area, and you treat them locally, right where the problem is.

That difference matters more than almost anything else on this page.A pill for hot flashes won’t fix painful sex. A vaginal treatment won’t touch a body-wide heat wave. When we get to specific options, we’ll keep these two buckets separate — because the biggest mistake we see on other sites is mashing them into one list.

→ Not sure which bucket you’re in? Get your personalized action plan with Find My HRT Path — free, about 90 seconds. You’ll get a symptom-first plan, not another wall of text.

First, why can’t you take estrogen? (This changes your options)

Your reason for avoiding estrogen — a hormone-sensitive cancer, a clot history, a stroke or heart problem, liver disease, or personal choice — changes which non-estrogen options are appropriate for you. For example, some antidepressants used for hot flashes interact with tamoxifen, and one hot-flash drug is off-limits if you have cirrhosis. Matching the option to the reason is the whole game.

This is the step most guides skip. They hand you a flat list of “non-hormonal options” as if every woman who lands here is the same. You’re not. A breast cancer survivor on tamoxifen, a woman with a past blood clot, and someone who’s simply nervous about hormones need three different conversations.

Your reason for avoiding estrogen → what fits

Your reasonNon-estrogen options usually on the tableThe flag to know
Hormone-sensitive (ER+) breast cancerNK3-receptor drugs Veozah and Lynkuet; the SNRIs venlafaxine and desvenlafaxine; gabapentin; CBT and clinical hypnosis; for vaginal symptoms, non-hormonal moisturizers, vaginal DHEA, or ospemifeneIf you're on tamoxifen, avoid paroxetine and fluoxetine — they can affect how tamoxifen works (see the next section). Veozah and Lynkuet are nonhormonal, but their labels don't establish breast-cancer recurrence safety, so your cancer team should be in the loop.
Past blood clot (DVT/PE) or a clotting disorderNK3 drugs; SSRIs/SNRIs; gabapentin; behavioral therapy; vaginal moisturizers and DHEAOral estrogen carries the highest clot risk. Even some non-estrogen pills, like the SERM ospemifene, carry a clot-class warning — flag your history.
Past stroke or heart attackNK3 drugs; SSRIs/SNRIs; gabapentin; behavioral therapyThe Menopause Society lists cardiovascular disease as a reason women are usually not good candidates for systemic hormones.
Active liver diseaseSSRIs/SNRIs and gabapentin (with monitoring); behavioral therapyVeozah is not for you if you have cirrhosis. Both NK3 drugs need liver blood tests. Tell your prescriber.
Unexplained vaginal bleedingNothing hormone-adjacent until it's worked up — bleeding comes firstUndiagnosed bleeding after menopause is a labeled contraindication for many systemic estrogen products and several vaginal prescriptions. Get it evaluated before any treatment.
Personal choice, no medical reasonThe full non-hormonal menu can be discussed — each option still has its own cautions — and, honestly, modern hormone therapy might still be worth a conversation"Can't" and "would rather not" are different. If it's a choice, a clinician can walk you through the real, updated risk picture before you rule estrogen out for good.

Sources: The Menopause Society 2023 Nonhormone Therapy Position Statement; FDA prescribing information for Veozah, Lynkuet, and Brisdelle; American Cancer Society guidance on menopausal hormone therapy after cancer.

One quick myth to kill: “compounded” or “bioidentical” hormones are not a loophole.They are not FDA-approved, the FDA has said it has no evidence they’re safer or more effective than approved products, and if a compound contains estrogen (many do — estriol is an estrogen), it’s still estrogen. If you can’t take estrogen, a custom-mixed estrogen cream doesn’t change that.

The best non-estrogen options for hot flashes and night sweats

For hot flashes and night sweats without estrogen, the FDA-approved options are the NK3-receptor drugs fezolinetant (Veozah) and elinzanetant (Lynkuet), plus low-dose paroxetine (Brisdelle). Beyond those, venlafaxine, desvenlafaxine, escitalopram, and gabapentin are used off-label with good evidence, and behavioral therapies like CBT and clinical hypnosis help too. Each has real trade-offs on cost, side effects, and monitoring.

“NK3-receptor drug” just means a newer class built to target the exact brain switch that triggers a hot flash — the first medicines designed for this instead of borrowed from another use.

The non-estrogen VMS toolkit

OptionWhat it isFDA-approved for menopause hot flashes?What to knowRough cost
Fezolinetant (Veozah)⚠ BOXED WARNINGNK3-receptor drug, one pill dailyYes — approved May 2023Carries a boxed warning for rare liver injury (added December 2024) and needs scheduled liver blood tests. Contraindicated with cirrhosis, severe kidney disease, or CYP1A2-inhibiting medicines. Nonhormonal — but that alone doesn't establish safety after breast cancer.High, no generic — confirm your pharmacy's price
Elinzanetant (Lynkuet)Newer dual-target NK-receptor drug, taken at bedtimeYes — approved October 24, 2025No boxed warning. Still needs liver tests at baseline and 3 months; not recommended in moderate-to-severe liver disease. Not during pregnancy; caution with a seizure history; can cause drowsiness; avoid grapefruit. Sleep scores improved in trials.Cash price vs. manufacturer savings differ sharply — confirm yours
Low-dose paroxetine (Brisdelle)⚠ BOXED WARNINGAn SSRI at a low 7.5 mg bedtime doseYes — approved 2013 (the only FDA-approved SSRI for hot flashes)Carries a boxed warning for suicidal thoughts and behaviors (from antidepressant data in children and young adults). Interacts with tamoxifen — see the next section.Low
Venlafaxine / desvenlafaxine / escitalopramSSRIs and SNRIs, used off-labelNo (off-label, but well-studied)Same SSRI/SNRI class warning. Often chosen over paroxetine if you take tamoxifen — though not a perfect green light (see the next section).Low
GabapentinA nerve medicine, used off-labelNo (off-label)Can cause drowsiness — often a plus for night sweats and sleep. No tamoxifen interaction.Low
OxybutyninA bladder medicine, used off-labelNo (off-label)Can help hot flashes, but long-term use of this drug class has been linked to memory concerns — usually a short-term or backup choice.Low
CBT and clinical hypnosisStructured behavioral therapyNot a drugReal evidence, no drug interactions, safe alongside anything. Endorsed by The Menopause Society.Varies
One clarification: Duavee (conjugated estrogens plus bazedoxifene) is FDA-approved for hot flashes, but it contains estrogen, so it is not an option on this page. If you truly can’t take estrogen, it’s off the table.

Want the full drug-by-drug breakdown — doses, side effects, and how to get each one? That lives on our non-hormonal options guide, so we won’t repeat all of it here.


Does non-estrogen menopause treatment actually work?

Yes — for many women, meaningfully. The NK3-receptor drugs were purpose-built to target the brain mechanism behind hot flashes, and in the trials that led to their approval, they cut both how often and how severe hot flashes were. SSRIs, SNRIs, and gabapentin have decades of use for vasomotor symptoms. These treatments generally reduce symptoms rather than erase them, and results vary from person to person.

Here’s the honest version. If you’ve heard “non-hormonal doesn’t really work,” that’s usually a comparison to estrogen — which is the most effective option and sets a high bar. Against that bar, non-estrogen treatments are a step down for some women and plenty good for others. Fezolinetant, in its approval trials, meaningfully lowered hot flash frequency and severity, and many women also report better sleep. The SNRIs and gabapentin have helped women manage hot flashes for years, especially breast cancer survivors who were never candidates for hormones in the first place.

What doesn’thave the evidence: most “natural hormone balance” supplements, over-the-counter herb stacks, and cooling gadgets marketed as cures. The FDA has said plainly that it doesn’t know whether many marketed herbs and “natural” menopause products are helpful or safe. We’re not going to pretend a supplement is the equal of a prescription that went through clinical trials. It isn’t.


The tamoxifen catch most pages miss

Key point:If you take tamoxifen, the medicines usually avoided for hot flashes are paroxetine (including low-dose Brisdelle) and fluoxetine — strong inhibitors of the enzyme that turns tamoxifen into its active form. Venlafaxine and gabapentin are the choices most often used instead, with gabapentin the cleanest on this specific interaction. This interaction is specific to tamoxifen; if you’re on an aromatase inhibitor rather than tamoxifen, it does not apply the same way.

Tamoxifen doesn’t do its job until your liver converts it into an active form called endoxifen. That conversion runs through a liver enzyme called CYP2D6. Certain antidepressants block that enzyme — and if you block it, you get less endoxifen. Paroxetine, a strong blocker, has been shown to cut endoxifen substantially (by roughly two-thirds in one well-known study). Whether that translates into worse cancer outcomes is genuinely uncertain — the outcome studies conflict — but paroxetine’s own label says to weigh the benefit against a possible reduction in tamoxifen’s effectiveness and consider avoiding it for hot flashes. That’s why paroxetine and fluoxetine are generally the ones to avoid.

Non-estrogen hot-flash drugEffect on the CYP2D6 enzymeWith tamoxifenWith aromatase inhibitors
Paroxetine (incl. Brisdelle), fluoxetine⚠ generally avoided with tamoxifenStrong blockerGenerally avoided — can lower active tamoxifen; clinical impact still uncertainNot the same concern
VenlafaxineWeakCommonly chosen — but a 2025 study still found a median ~15% dip in active tamoxifen, so not automaticNo CYP2D6 issue
DesvenlafaxineWeakReasonable option; discuss with your teamNo CYP2D6 issue
GabapentinNoneCleanest choice — essentially no effect on active tamoxifenNo CYP2D6 issue

The nuance that makes this trustworthy: the problem is about tamoxifen specifically, not “breast cancer” in general. If you had breast cancer but you’re on an aromatase inhibitor(like anastrozole, letrozole, or exemestane) instead of tamoxifen, aromatase inhibitors don’t depend on that CYP2D6 conversion — so this particular interaction doesn’t hit you the same way. A page that just says “avoid antidepressants if you had breast cancer” gets it wrong in both directions. Bring your exact medication list to your prescriber, and this gets sorted in a sentence or two.


“Non-hormonal” doesn’t mean “risk-free” — the honest part

Non-estrogen doesn’t mean no risk. Two of the three FDA-approved non-hormonal hot-flash drugs carry the FDA’s most serious “boxed” warning — Veozah for rare liver injury, and low-dose paroxetine (Brisdelle) for suicidal thoughts in young adults. Veozah also requires scheduled liver blood tests. These risks are manageable with a clinician, but you deserve to know them going in, not after.

We’re telling you this on purpose, because you’re going to hear “hormone-free relief” marketed as automatically safer, and it’s not that simple. Here’s the plain ledger:

  • Veozah (fezolinetant) carries a boxed warning for rare but serious liver injury, added in December 2024. It requires liver blood tests before you start and on a set schedule after.
  • Brisdelle (low-dose paroxetine) carries the SSRI class boxed warning for suicidal thoughts and behaviors, mostly a concern in younger adults.
  • Lynkuet (elinzanetant), the newest option, does notcarry a boxed warning in its current U.S. label. It still needs early liver tests and isn’t for use in pregnancy — but on this one measure, it’s the cleaner label of the three.

So the real takeaway isn’t “avoid these.” Millions of women take them safely. The takeaway is that “non-hormonal” is a useful category, not a magic word — every option here has trade-offs, and a good provider will walk you through yours before writing the prescription. That honesty is the whole point of care.


Vaginal dryness, painful sex, and bladder symptoms without estrogen

Vaginal and urinary symptoms have their own non-estrogen toolkit: non-hormonal moisturizers and lubricants first, then prescription vaginal DHEA (prasterone, brand name Intrarosa), and the oral pill ospemifene (Osphena). Low-dose vaginal estrogen has low — not zero — absorption into the bloodstream and is sometimes used even in survivors, but it is still estrogen, so whether it’s right for you depends on why you can’t take estrogen, and it’s a decision to make with your care team.

Remember the two buckets. Everything above was for hot flashes. This is the other bucket — genitourinary syndrome of menopause (GSM). A hot-flash pill does nothing for this.

The non-estrogen GSM toolkit

OptionWhat it isIs it estrogen?What to know
Moisturizers (regular use) + lubricants (for sex)Over-the-counter, non-hormonalNoAlways the first step. Moisturizers on a regular schedule; lubricants for intimacy. Follow the product's directions and stop if you get irritation. Inexpensive, no prescription needed.
Vaginal DHEA / prasterone (Intrarosa)A vaginal insertConverts to estrogen locallyNot estrogen itself, but the body turns it into estrogens and androgens. FDA-approved for painful sex. Its label states estrogen is a metabolite and that it hasn't been studied in women with a breast-cancer history. Some studies find blood estrogen stays in the normal postmenopausal range, and ASCO supports it for some survivors on aromatase inhibitors who've failed other options — but this is an oncology-involved decision.
Ospemifene (Osphena)A daily systemic pill (a SERM)No (but systemic)Carries a boxed warning for endometrial-cancer and cardiovascular/clot risks, and is contraindicated with a clot history (DVT/PE), arterial clots, estrogen-dependent cancer, undiagnosed bleeding, or pregnancy. Its U.S. label says it should not be used with known, suspected, or prior breast cancer; ACOG says it may still be considered case by case. An oncology-aware decision.
Low-dose vaginal estrogen (listed so you're not confused — this IS estrogen)Local cream, tablet, insert, or ringYesSystemic absorption is generally low — but low, not zero, and it varies by product and dose. Sometimes used even in survivors after a shared decision. It is estrogen, so it belongs in the 'talk to your team' column. See our vaginal estrogen guide for the full picture.

Two things worth saying out loud. First, if your only real problem is vaginal or urinary, a clinic that only prescribes hot-flash pills is the wrong providerfor you — you want someone who treats GSM directly. Second, not every dryness or burning symptom is menopause — conditions like Sjögren’s or lichen sclerosus can mimic GSM, and lichen sclerosus needs a steroid, not estrogen. If moisturizers and the usual steps aren’t helping, that’s a reason to get examined, not to give up.

Want the deeper dive on how vaginal estrogen absorption actually works? We cover it on our vaginal estrogen guide.


The best online providers for menopause treatment without estrogen

For most women who want to start online, Midi Health is our first pick: it runs a dedicated care pathway for cancer survivors and women who can’t take hormones, prescribes non-estrogen options rather than defaulting to estrogen, and is in-network with most PPO plans. If you want to pay cash or choose your own clinician, Sesame is a solid alternative— but note it doesn’t serve anyone on Medicaid or Medicare. Providers whose menopause programs are built around estrogen or compounded hormones aren’t the right tool for this search.

ProviderBest forPrescribes non-estrogen hot-flash meds?Insurance / cashThe main catch
Midi HealthsponsoredMost women who want a menopause clinician, especially complex or cancer historiesYes — non-estrogen options, with a cancer-survivor pathway (confirm the specific drug on intake)In-network with most PPO plans; self-pay about $250 first visit, $150 follow-upCan't treat Medicaid or Medi-Cal patients; Medicare is self-pay only; HMO participation varies by plan
SesamesponsoredEligible cash-pay, or anyone who wants to pick their own clinicianYes, through the clinician you bookCash-pay, no insurance billing; general visits from about $34; labs included when ordered (except a few states)Not available if you have Medicare or Medicaid; it's a marketplace, so clinician menopause expertise varies — choose carefully
Gennevnot an affiliate — listed for completenessWomen who want a menopause-trained doctor plus a dietitian optionYes (FDA-approved non-hormonal prescribing)Insurance accepted; self-pay about $250 first visitDoesn't publicly spell out a dedicated cancer-survivor pathway
Evernownot an affiliate — listed for completenessA lower-cost, nationwide, message-first optionYes — publicly lists Veozah and paroxetineMajor commercial plans; membership options plus self-pay video visitsNo Medicare or Medicaid; medication billed separately

✔ What we actually verified ()

  • Midi states on its own site that it offers prescription and lifestyle options for cancer survivors and women at elevated breast-cancer risk. Confirm the exact medicine it will prescribe and monitor on intake.
  • Midi is in-network with most PPO plans and is not enrolled with Medicare or Medicaid. Medicaid and Medi-Cal patients can’t be treated; Medicare beneficiaries can self-pay only, without submitting claims; HMO participation varies by carrier and state.
  • Sesame doesn’t bill insurance and requires you to certify that you are not a Medicare, Medicaid, or TRICARE beneficiary. General visits from about $34; gynecology pricing varies by ZIP. Basic labs included when ordered, with state exceptions (NY, NJ, RI: pay Quest directly; ND: use a lab of your choice).
  • Veozah has no generic; as a July 2026 reference, one national discount service showed roughly $573 with a coupon versus about $777 average retail for 30 tablets — prices vary by pharmacy, quantity, and location, so confirm yours. Lynkuet is a newer launch; confirm its cash price and any manufacturer savings live.

Prices and insurance networks change. Confirm the number that applies to you at intake or checkout.

Midi Health — best for most women who can’t take estrogen

If your real question isn’t just “can someone write me a prescription?” but “can an online clinician handle my cancer history, my other medications, my labs, and pick the right non-estrogen option?” — that’s Midi. It operates in all 50 states, its clinicians specialize in menopause, and it prescribes non-estrogen options rather than defaulting to hormones. The reason it leads this page: it runs a dedicated pathway for cancer survivors and women who can’t take hormones, so it can manage a complex history and order and follow the lab monitoring that a drug like Veozah requires.

See Midi’s coverage and appointment availability (sponsored)

Sponsored. We may earn a commission if you start care with Midi, and it never affects our rankings. Our affiliate disclosure.

The honest part: Midi does not treat Medicaid or Medi-Cal patients — not even self-pay. Medicare beneficiaries can use it self-pay only, and HMO participation varies by plan and state. We’d rather tell you now than waste your time. If you have Medicaid or Medi-Cal, Midi isn’t your path — and neither is Sesame, which doesn’t serve federal programs either. Skip ahead to what to do if you’re on Medicaid or Medicare.

Sesame — best for eligible cash-pay, or choosing your own clinician

Sesame is a marketplace where you book a real clinician at a transparent cash price, with no insurance in the middle. General visits start around $34 (menopause and gynecology visits run higher and vary by location, so check your price before booking), medications are billed separately, and when a clinician orders labs, they’re usually included — with some state exceptions. One important limit: Sesame requires you to certify that you are not a Medicare, Medicaid, or TRICARE beneficiary, so it is not a route for anyone on a federal health program.

Browse menopause clinicians and prices on Sesame (sponsored)

Sponsored. We may earn a commission if you start care with Sesame, and it never affects our rankings. Our affiliate disclosure.

The one caveat: Sesame is a marketplace, so a clinician’s comfort with a complex cancer or drug-interaction history varies from provider to provider. If your case is complicated, read the clinician’s profile, and bring the checklist from further down this page.

If you have Medicaid or Medicare, start here

Here’s the gap the internet usually leaves you to fall through, said plainly: the two routes above don’t serve federal-program beneficiaries, so pushing you toward them would only waste your time. Instead:

  • Start with your plan’s in-network gynecologist or primary-care clinician. Many now prescribe fezolinetant, low-dose paroxetine, and off-label options, and your plan may cover both the visit and the medication.
  • If you have a cancer history, ask your oncology team directly — they often manage or coordinate menopause symptoms for their patients, and they already have your treatment records.
  • Ask your plan about any contracted, in-network telehealth or menopause service available to you.

This route matters as much as any recommendation on this page — maybe more, because it’s the one most sites skip. You are not out of options; you just start through your plan rather than a cash-pay clinic.

Who we didn’t feature, and why

A provider can be perfectly legitimate and still be the wrong tool for thissearch. We left three off the featured list on purpose, and it costs us nothing to tell you why — two of them actually pay us:

  • Hers— its menopause program is built around estrogen (estradiol pills, patches, and vaginal cream). That’s the wrong tool for a woman who can’t take estrogen.
  • Winona— its menopause pathway is HRT-centered, offering FDA-approved estrogen products alongside compounded hormone creams; its non-HRT list isn’t a full nonhormonal hot-flash program for this reader.
  • Inner Balance (Oestra)— a compounded, systemic estradiol-and-progesterone product, which is the opposite of a non-estrogen option. Compounded estrogen is still estrogen, and it’s not FDA-approved.

If a clinician later clears you for estrogen — it happens, especially if your reason was caution rather than a hard contraindication — those options may come back on the table, and our best HRT providers guide covers them. But for a page about treating menopause withoutestrogen, an estrogen-based program isn’t the answer.


What non-estrogen menopause treatment actually costs

The real number isn’t the visit fee — it’s your first 90 days all in.That includes the first visit, a follow-up, the medication, any required labs, and what your insurance does or doesn’t cover. Generic antidepressants and gabapentin are cheap. The newer NK3-receptor drugs are the expensive ones. Veozah has no generic and runs high — as a July 2026 reference, one national discount service showed roughly $573 with a coupon versus about $777 average retail for 30 tablets in one ZIP; confirm yours. Lynkuet’s ordinary cash price is separate from its manufacturer savings program, which can bring eligible commercially insured patients to as little as $25 — an offer that doesn’t apply if you’re uninsured or on a federal plan.

Don’t judge cost by the sticker on the first visit. Here’s what to add up.

Cost layerThe question to ask
First visitIs it a flat fee, or part of a membership? (Midi self-pay: ~$250. Sesame: from ~$34 for general visits.)
Follow-upWhen's the first one, and what does it cost? (Midi self-pay: ~$150.)
MedicationCheap generic, or a pricey brand? (Veozah: no generic, runs several hundred/month — confirm your pharmacy's price. SSRIs/SNRIs and gabapentin: inexpensive.)
LabsIncluded, billed to insurance, or paid separately? (Sesame includes them when ordered, except NY/NJ/RI/ND.)
InsuranceDoes it cover the visit, the drug, both, or neither? Is your provider in-network?
Prior authorizationWill the provider file it for the newer drugs? Is there a fee?

The pattern most women land on: an inexpensive generic like venlafaxine or gabapentin keeps the whole thing cheap, while choosing Veozah or Lynkuet makes the medication your biggest line item. If you have PPO insurance, verifying coverage before you commit is the single highest-value move. Our full menopause cost breakdown has the detailed numbers.


The labs and monitoring a safe plan includes

Monitoring depends on the drug. The one to know is Veozah: the FDA requires a liver blood test before you start, then monthly for the first three months, and again at months six and nine. A credible online provider should be able to order those tests, receive the results, and act on them. If a clinic can prescribe Veozah but can’t manage the liver monitoring, that’s a mismatch.

Here’s the Veozah schedule, exactly as the FDA lays it out:

WhenWhat’s required
Before you startBaseline liver blood test
Month 1Liver blood test
Month 2Liver blood test
Month 3Liver blood test
Month 6Liver blood test
Month 9Liver blood test

The FDA also says to stop the drug and call your prescriber right away if you notice signs of liver trouble — yellowing skin or eyes, dark urine, unusual tiredness, nausea, or pain in the upper-right belly. Lynkuet needs early liver testing too; confirm its exact schedule against the current label with your prescriber. The generic antidepressants and gabapentin don’t require this kind of scheduled liver testing, but your clinician will still review your other medicines, your kidney and liver history, and — if you’re on tamoxifen — that interaction from earlier.

The questions worth asking any provider before you start a monitored drug: Who orders the tests? Which lab can I use? Are they included? Who calls me about an abnormal result? And can you stop or switch the medicine quickly if something looks off?


When online care is the wrong first step

Online care is a great starting point for many women who can’t take estrogen — but not all. Unexplained vaginal bleeding, a complex cancer situation that needs oncology coordination, or severe symptoms with warning-sign features are reasons to start (or stay) with an in-person clinician.

Start (or stay) with an in-person or specialist visit if any of these apply:

SituationWhere to go
New or unexplained vaginal bleeding after menopauseIn-person evaluation, promptly — before any treatment
Sudden weakness, trouble speaking, severe chest pain or shortness of breathEmergency care now
Yellowing skin or eyes, dark urine, or bad upper-belly pain while on VeozahStop the drug, call your prescriber; urgent evaluation may be needed
A new breast, pelvic, or vaginal finding that needs an examIn-person clinician
An active cancer-treatment decision or an unresolved oncology questionOncology-led or coordinated care
Thoughts of harming yourselfCall or text 988 (the U.S. Suicide & Crisis Lifeline), or go to an emergency room

If you’re not sure whether online care fits your situation, the quiz flags it before you pay a cent.

Take the free Find My HRT Path quiz — it’ll tell you if online care is a reasonable starting point for you, or if you should see someone in person first.

How we chose these providers

We review providers on five things, in this order: clinical legitimacy, care quality, medication fit, price transparency, and access.We read every published price, keep FDA-approved and compounded options strictly separate, verify state availability and insurance, and re-check on a fixed schedule — top providers monthly, the full roster quarterly. Every medical claim on this page traces to a primary source like the FDA or The Menopause Society, and every price to a dated source.

We call this the HRT Index Verification Standard, and it’s why this page reads differently from a typical “best of” list. We don’t score providers with a number, and we don’t rank by who pays the most. Midi leads this page because it’s the strongest fitfor a woman who can’t take estrogen — a dedicated cancer-survivor pathway, non-estrogen prescribing, and lab coordination — and it happens to be a partner. When the best fit and our business interests point different directions, fit wins. That’s exactly why we told you Hers doesn’t belong here even though it pays us.

What we verified from primary sources: each provider’s published prices, insurance model, state availability, the medications each publicly describes prescribing, and their FDA-approved-versus-compounded policy — plus the current FDA status and monitoring rules for every drug named here. What we didn’t test: actual checkout totals for your specific plan, individual copays, or the experience of one particular clinician. You can read the full method on our methodology page.


Your first-appointment checklist

A good first visit should clarify why estrogen was ruled out, name the symptom you’re treating, review your medications and history, and set up exactly how monitoring and follow-up will work. You should leave with a reasoned plan — not just a prescription or a supplement suggestion. Copy these questions and bring them.

  1. When you say I shouldn't take estrogen, do you mean systemic estrogen, all estrogen products, or a specific type?
  2. What's the main symptom this treatment is meant to fix?
  3. Is what you're recommending FDA-approved for that symptom, used off-label, or compounded?
  4. Does it interact with tamoxifen, an aromatase inhibitor, or any medicine I already take? (Bring your full list.)
  5. What lab tests do I need before I start, and on what schedule after?
  6. Who orders and reviews those tests, and who calls me if something's off?
  7. What symptoms mean I should stop and call you?
  8. What happens if the first treatment doesn't work?
  9. What will my first 90 days cost — visit, medication, and labs?
  10. Will you handle prior authorization if I need one of the newer drugs?
  11. Does this plan cover my vaginal, sleep, or mood symptoms too, or only hot flashes?
  12. Do I need an in-person exam or my oncologist's input before we start?
Build your plan with Find My HRT Path and take these questions into your first visit — free, about 90 seconds.

Frequently asked questions

What is the best non-hormonal treatment for hot flashes?

There isn't a single best one for everyone. The FDA-approved options are fezolinetant (Veozah), elinzanetant (Lynkuet), and low-dose paroxetine (Brisdelle); venlafaxine, desvenlafaxine, and gabapentin are common off-label choices. The right pick depends on your other medicines, your history, cost, and your prescriber's judgment.

Can I take Veozah if I've had breast cancer?

A breast-cancer history isn't itself a listed contraindication for Veozah — but that doesn't make the answer automatically yes. Veozah is nonhormonal, though its label doesn't establish recurrence safety, so a prescriber should weigh your cancer treatment along with your liver and kidney health and any interacting medicines. Decide it with a clinician who knows your history. It also carries a boxed warning for rare liver injury and requires scheduled liver blood tests.

What can I take for menopause if I'm on tamoxifen?

For hot flashes, venlafaxine and gabapentin are the choices most often used instead (gabapentin has essentially no effect on the active form of tamoxifen). The medicines usually avoided are paroxetine (including Brisdelle) and fluoxetine, which can lower it. This is specific to tamoxifen, not aromatase inhibitors — and it's a conversation to have with your prescriber and oncology team.

Is there a non-estrogen treatment for vaginal dryness?

Yes. Start with non-hormonal moisturizers and lubricants, then talk to a clinician about vaginal DHEA (prasterone/Intrarosa — which converts to estrogen locally, so it's a decision to make with your care team) or the systemic pill ospemifene (Osphena, which carries a boxed warning). Low-dose vaginal estrogen is a separate, estrogen-containing option to discuss with your care team.

Do online providers prescribe non-hormonal menopause treatment?

Yes. Midi prescribes non-estrogen options and runs a cancer-survivor pathway, and Sesame connects you to a clinician who can (if you're not on Medicare or Medicaid). Both let you handle it from home, though monitored drugs like Veozah require labs the provider must be able to order and follow.

Is non-hormonal menopause treatment safe?

Generally yes, with a clinician's oversight — but 'non-hormonal' doesn't mean 'risk-free.' Two of the three FDA-approved non-hormonal hot-flash drugs carry boxed warnings, and Veozah needs liver monitoring. Your provider should walk you through your specific risks.

Can I get menopause treatment without estrogen if I'm on Medicaid?

Yes — but not through the cash-pay routes on this page. Neither Midi nor Sesame serves Medicaid (Sesame requires you to certify you're not a federal-program beneficiary). Start with your plan's in-network gynecologist or primary-care clinician, or your oncology team if you have a cancer history. The medications themselves — especially the generic ones — are often affordable regardless of provider.

Does insurance cover non-hormonal menopause treatment?

Often, for the medications, especially generics. Coverage of the newer NK3-receptor drugs varies, so check your plan's formulary. Visit coverage depends on whether your provider is in-network — Midi works with many PPO plans, while Sesame is cash-pay.

I saw the news that hormone therapy is 'safe now.' Does that mean I can take estrogen after all?

Recent FDA label updates changed some of the warnings on menopausal hormone therapy, but they didn't rewrite who's a candidate. A personal history of hormone-sensitive breast cancer, a serious clot, or certain other conditions still means systemic estrogen usually isn't appropriate. Only your clinician can tell you if your specific situation has changed.


The bottom line

You’re not stuck, and you’re not out of options — you’re just working with a different toolkit than someone who can take hormones. Match the treatment to your reason and yourmain symptom: NK3-receptor drugs, certain antidepressants, or gabapentin for hot flashes; moisturizers, vaginal DHEA, or ospemifene for vaginal symptoms; and a provider who can prescribe the right one and manage your history. For most women who want to start online, that provider is Midi. If you’re paying cash or want to choose your clinician, Sesame is a solid alternative — and if you’re on Medicaid or Medicare, start with in-network or oncology care.

Still not sure which path is right for you? Take our free Find My HRT Path matching quiz — about 90 seconds, and it’s built for exactly this decision.


Sources

  • The Menopause Society (formerly NAMS). The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society. Menopause. 2023;30(6):573–590.
  • U.S. Food & Drug Administration. Prescribing information and drug safety communications for Veozah (fezolinetant), including the December 2024 boxed warning for liver injury and required liver monitoring.
  • U.S. Food & Drug Administration. Approval and prescribing information for Lynkuet (elinzanetant), approved October 24, 2025.
  • U.S. Food & Drug Administration. Prescribing information for Brisdelle (paroxetine 7.5 mg).
  • U.S. Food & Drug Administration. Menopause (consumer health information) and guidance on compounded “bioidentical” hormones.
  • American Cancer Society; The Menopause Society; ACOG — guidance on menopausal symptom management and genitourinary symptoms in women with a history of estrogen-dependent breast cancer.
  • Cleveland Clinic Journal of Medicine and peer-reviewed literature on non-estrogen management of genitourinary syndrome of menopause in cancer survivors (vaginal DHEA/prasterone, ospemifene, and local estrogen absorption).
  • Provider sources (verified July 2026): Midi Health, Sesame, Gennev, and Evernow published pricing, insurance, and treatment information.